Skip to main content
OpenTrials

Clinical trial condition

Conjunctival Diseases

Explore clinical trials studying Conjunctival Diseases. Study availability and eligibility vary by location and protocol.

452 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Conjunctival Diseases trial results

Completed

Study of Rebamipide Eye Drops to Treat Dry Eye

NCT00201955

Conditions
Conjunctival Diseases, Conjunctivitis, Corneal Diseases, +6 more
Locations
  • Harold Helms, MD Birmingham, Alabama, United States
  • Michael Bernstein, MD Birmingham, Alabama, United States
  • I Care! Eye Care! Flagstaff, Arizona, United States
  • Harvey and Bernice Jones Eye Institute Little Rock, Arkansas, United States
View all 60 locations
View Trial Details
Completed

A 1-Year Study in Multiple Clinics Testing Rebamipide Eye Drops for Dry Eye Compared With a Placebo

NCT00201981

Conditions
Conjunctival Diseases, Conjunctivitis, Corneal Diseases, +6 more
Locations
  • Alabama Research Center, LLC Birmingham, Alabama, United States
  • Sun Valley Arthritis Center, Ltd. Glendale, Arizona, United States
  • Pivotel Research Center Peoria, Arizona, United States
  • Hope research Institute Phoenix, Arizona, United States
View all 63 locations
View Trial Details
Completed

RMP-A03 Ocular Suspension in Patients With Pterygium

NCT05794204

Conditions
Conjunctival Diseases, Eye Diseases, Pterygium
Locations
  • Global Research Management Glendale, California, United States
  • United Medical Research Institute Inglewood, California, United States
  • Eye Research Foundation Inc Newport Beach, California, United States
  • Oceane7 Medical & Research Center Inc. Miami, Florida, United States
View Trial Details
Completed

A Study to Demonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat Allergy

NCT06602726

Conditions
Allergic Conjunctivitis, Conjunctival Diseases, Conjunctivitis, +5 more
Locations
  • Andover Eye Associates Andover, Massachusetts, United States
  • Kingston Health Sciences Centre Kingston, Ontario, Canada
  • Red Maple Trials Inc. Ottawa, Ontario, Canada
  • Clinique de Specialisee en Allergie de la Capitale Québec, Canada
View Trial Details
Completed

Ophthalmological Adverse Events of Tralokinumab in AD

NCT05682976

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Conjunctival Diseases, +12 more
Locations
  • CHU de Bordeaux Bordeaux, France
  • CHU de Brest Brest, France
  • CHU de Clermont Ferrand Clermont-Ferrand, France
  • CHu de Dijon Dijon, France
View Trial Details

Related conditions